Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    23547081 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine plus TS-1;   Drug: TS-1;   Drug: Gemcitabine
2 Recruiting Combination of Stereotactic Body Radiation Therapy With S-1 for Treating Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Other: combination of Cyberknife with S-1

Study has passed its completion date and status has not been verified in more than two years.